Service of Electrophysiology, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
Service of Electrophysiology and Cardiac Stimulation, University Hospital of Bordeaux, Pessac, France.
Heart Rhythm. 2019 Jul;16(7):1047-1056. doi: 10.1016/j.hrthm.2019.01.020. Epub 2019 Jan 23.
Patient-specific programming of cardiac resynchronization therapy (CRT) is often neglected, despite significant nonresponse rates. The device-based SyncAV CRT algorithm dynamically adjusts atrioventricular delays to the intrinsic AV interval, reduced by a programmable offset, to accommodate each patient's changing needs.
The purpose of this study was to evaluate the acute effect of biventricular (BiV) pacing enhanced by SyncAV on electrical synchrony in a broad patient population.
Patients with existing CRT implants were prospectively evaluated at 5 international centers. Blinded 12-lead electrocardiographic QRS duration (QRSd) measurements were used to compare intrinsic conduction with nominal BiV pacing, BiV + SyncAV (default 50 ms offset), and BiV + SyncAV (optimized, patient-specific offset). BiV configurations were tested twice using the latest activating and earliest activating left ventricular (LV) electrodes as cathodes.
Ninety patients (mean age 67.1 ± 9.5 years; 67 (74%) men; 55 (63%) with left bundle branch block; 37 (43%) with ischemic cardiomyopathy; LV ejection fraction 32% ± 9%) with intact atrioventricular conduction (PR interval 195 ± 45 ms) were enrolled. With BiV pacing from the latest activating LV electrode, the intrinsic QRSd of 155 ± 29 ms was reduced by 9% ± 20% to 138 ± 27 ms using traditional BiV pacing and by 13% ± 14% to 133 ± 25 ms using BiV + SyncAV (50 ms offset). The maximal QRSd reduction by 20% ± 10% to 123 ± 22 ms was achieved by BiV + SyncAV with an optimized offset. Similar QRSd reductions were observed with BiV pacing from the earliest activating LV electrode across all settings. Of all baseline characteristics, intrinsic QRSd was the only significant predictor of QRSd reduction magnitude.
SyncAV improved acute electrical synchrony beyond conventional CRT, particularly with patient-specific optimization. The degree of synchrony restored was contingent on intrinsic QRSd, but not limited by other baseline characteristics or by the LV pacing electrode used.
尽管存在明显的无应答率,但患者特异性心脏再同步治疗(CRT)编程通常被忽视。基于设备的SyncAV CRT 算法可以动态调整房室延迟,以适应每个患者的变化需求,方法是将固有 AV 间隔缩短一个可编程的偏移量。
本研究旨在评估广泛患者人群中双心室(BiV)起搏增强 SyncAV 的急性效果对电同步的影响。
前瞻性评估了 5 个国际中心的 90 例现有 CRT 植入患者。使用 12 导联心电图 QRS 持续时间(QRSd)测量值比较固有传导与标称 BiV 起搏、BiV+SyncAV(默认 50 ms 偏移量)和 BiV+SyncAV(优化、患者特异性偏移量)的情况。使用最新激活和最早激活的左心室(LV)电极作为阴极,对 BiV 配置进行了两次测试。
90 例患者(平均年龄 67.1 ± 9.5 岁;67(74%)名男性;55(63%)例左束支传导阻滞;37(43%)例缺血性心肌病;LV 射血分数 32% ± 9%)的房室传导完整(PR 间隔 195 ± 45 ms)。使用最新激活的 LV 电极进行 BiV 起搏时,固有 QRSd 为 155 ± 29 ms,使用传统 BiV 起搏可减少 9% ± 20%至 138 ± 27 ms,使用 BiV+SyncAV(50 ms 偏移量)可减少 13% ± 14%至 133 ± 25 ms。通过 BiV+SyncAV 实现最大 QRSd 减少 20% ± 10%至 123 ± 22 ms,使用优化的偏移量。在所有设置中,使用最早激活的 LV 电极进行 BiV 起搏时,均可观察到类似的 QRSd 减少。在所有基线特征中,固有 QRSd 是 QRSd 减少幅度的唯一显著预测因素。
SyncAV 改善了常规 CRT 之外的急性电同步性,特别是通过患者特异性优化。恢复的同步程度取决于固有 QRSd,但不受其他基线特征或使用的 LV 起搏电极的限制。